Nano-Strategies Targeting the Integrin αvβ3 Network for Cancer Therapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nano-Strategies Targeting the Integrin αvβ3 Network for Cancer Therapy
Authors
Keywords
-
Journal
Cells
Volume 10, Issue 7, Pages 1684
Publisher
MDPI AG
Online
2021-07-05
DOI
10.3390/cells10071684
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molybdenum Dioxide (MoS2)/Gadolinium (Gd) Containing Arginine-Glycine-Aspartic Acid (RGD) Sequences as New Nano-Contrast Agent for Cancer Magnetic Resonance Imaging (MRI)
- (2021) Xiaoguang Hao et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- HMGA2 as a Critical Regulator in Cancer Development
- (2021) Behzad Mansoori et al. Genes
- Migration and invasion of NSCLC suppressed by the downregulation of Src/focal adhesion kinase using single, double and tetra domain anti- CEACAM6 antibodies
- (2021) Shang-Jung Wu et al. Translational Oncology
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Combined Treatment of Heteronemin and Tetrac Induces Antiproliferation in Oral Cancer Cells
- (2020) Chi-Hung Huang et al. Marine Drugs
- NDAT Targets PI3K-Mediated PD-L1 Upregulation to Reduce Proliferation in Gefitinib-Resistant Colorectal Cancer
- (2020) Tung-Yung Huang et al. Cells
- Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status
- (2019) Yu-Tang Chin et al. Frontiers in Endocrinology
- Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol
- (2019) Adele Chimento et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Thyroxine promotes lung cancer growth in an orthotopic mouse model
- (2019) Soeren Latteyer et al. ENDOCRINE-RELATED CANCER
- Recent Strategies in Resveratrol Delivery Systems
- (2019) Noelia D. Machado et al. ChemPlusChem
- Multicomponent self nano emulsifying delivery systems of resveratrol with enhanced pharmacokinetics profile
- (2019) Teófilo Vasconcelos et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The Role of Thyroid Hormones in Hepatocyte Proliferation and Liver Cancer
- (2019) Fabio Gionfra et al. Frontiers in Endocrinology
- Switching from Conventional to Nano-natural Phytochemicals to Prevent and Treat Cancers: Special Emphasis on Resveratrol
- (2019) Salman Ul Islam et al. CURRENT PHARMACEUTICAL DESIGN
- Thyroid hormone-induced expression of inflammatory cytokines interfere with resveratrol-induced anti-proliferation of oral cancer cells
- (2019) Yi-Ru Chen et al. FOOD AND CHEMICAL TOXICOLOGY
- Integrin αvβ3-Mediated Effects of Thyroid Hormones on Mesenchymal Stem Cells in Tumor Angiogenesis
- (2019) Kathrin A. Schmohl et al. THYROID
- NDAT suppresses pro-inflammatory gene expression to enhance resveratrol-induced anti-proliferation in oral cancer cells
- (2019) Yih Ho et al. FOOD AND CHEMICAL TOXICOLOGY
- Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells
- (2018) Yu-Tang Chin et al. ENDOCRINE-RELATED CANCER
- Nano-diamino-tetrac (NDAT) inhibits PD-L1 expression which is essential for proliferation in oral cancer cells
- (2018) Shan-Jen Lin et al. FOOD AND CHEMICAL TOXICOLOGY
- Resveratrol inhibits human leiomyoma cell proliferation via crosstalk between integrin αvβ3 and IGF-1R
- (2018) Yih Ho et al. FOOD AND CHEMICAL TOXICOLOGY
- Tetraiodothyroacetic acid (tetrac), integrin αvβ3 and disabling of immune checkpoint defense
- (2018) Paul J Davis et al. Future Medicinal Chemistry
- Tetrac-decorated chitosan-coated PLGA nanoparticles as a new platform for targeted delivery of SN38
- (2018) Mona Alibolandi et al. Artificial Cells Nanomedicine and Biotechnology
- Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions
- (2018) Yifan Wang et al. Frontiers in Pharmacology
- Thyroid Hormone Promotes β-Catenin Activation and Cell Proliferation in Colorectal Cancer
- (2018) Yee-Shin Lee et al. Hormones & Cancer
- Nano-Diamino-Tetrac (NDAT) Enhances Resveratrol-Induced Antiproliferation by Action on the RRM2 Pathway in Colorectal Cancers
- (2018) André Wendindondé Nana et al. Hormones & Cancer
- Nanostructured Lipid Carriers as Promising Delivery Systems for Plant Extracts: The Case of Silymarin
- (2018) Vieri Piazzini et al. Applied Sciences-Basel
- Increased Oral Bioavailability of Resveratrol by Its Encapsulation in Casein Nanoparticles
- (2018) Rebeca Peñalva et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- EGF-induced nuclear localization of SHCBP1 activates β-catenin signaling and promotes cancer progression
- (2018) Lei Liu et al. ONCOGENE
- In tumor cells, thyroid hormone analogues non-immunologically regulate PD-L1 and PD-1 accumulation that is anti-apoptotic
- (2018) Hung-Yun Lin et al. Oncotarget
- Nano based drug delivery systems: recent developments and future prospects
- (2018) Jayanta Kumar Patra et al. JOURNAL OF NANOBIOTECHNOLOGY
- Enhancement by Nano-Diamino-Tetrac of Antiproliferative Action of Gefitinib on Colorectal Cancer Cells: Mediation by EGFR Sialylation and PI3K Activation
- (2018) Tung-Cheng Chang et al. Hormones & Cancer
- Health Concerns of Various Nanoparticles: A Review of Their in Vitro and in Vivo Toxicity
- (2018) Marziyeh Ajdary et al. Nanomaterials
- Integrin αvβ3-Targeted [64Cu]CuS Nanoparticles for PET/CT Imaging and Photothermal Ablation Therapy
- (2018) Lili Cui et al. BIOCONJUGATE CHEMISTRY
- Resveratrol: from enhanced biosynthesis and bioavailability to multitargeting chronic diseases
- (2018) Naveet Pannu et al. BIOMEDICINE & PHARMACOTHERAPY
- Microfluidization trends in the development of nanodelivery systems and applications in chronic disease treatments
- (2018) Palanivel Ganesan et al. International Journal of Nanomedicine
- Nano-Gold Loaded with Resveratrol Enhance the Anti-Hepatoma Effect of Resveratrol In Vitro and In Vivo
- (2018) Duoduo Zhang et al. Journal of Biomedical Nanotechnology
- Bioactivity of Thyroid Hormone Analogs at Cancer Cells
- (2018) Paul J. Davis et al. Frontiers in Endocrinology
- Tetrac downregulates β-catenin and HMGA2 to promote the effect of resveratrol in colon cancer
- (2017) André Wendindondé Nana et al. ENDOCRINE-RELATED CANCER
- Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac
- (2017) Thangirala Sudha et al. International Journal of Nanomedicine
- Integrin-targeted nano-sized polymeric systems for paclitaxel conjugation: a comparative study
- (2017) Anat Eldar-Boock et al. JOURNAL OF DRUG TARGETING
- Targeted delivery of cisplatin to tumor xenografts via the nanoparticle component of nano-diamino-tetrac
- (2017) Thangirala Sudha et al. Nanomedicine
- Cancer drug delivery in the nano era: An overview and perspectives
- (2017) Zhen Li et al. ONCOLOGY REPORTS
- Improving on Nature: The Role of Nanomedicine in the Development of Clinical Natural Drugs
- (2017) Anna Bilia et al. PLANTA MEDICA
- Exploring the Role of RGD-Recognizing Integrins in Cancer
- (2017) Markus Nieberler et al. Cancers
- Transforming growth factor β as regulator of cancer stemness and metastasis
- (2016) Claudia Bellomo et al. BRITISH JOURNAL OF CANCER
- Synergistic active targeting of dually integrin α v β 3 /CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies
- (2016) Sanjun Shi et al. JOURNAL OF CONTROLLED RELEASE
- The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction
- (2016) Nazanin Hoshyar et al. Nanomedicine
- The combination of tetraiodothyroacetic acid and cetuximab inhibits cell proliferation in colorectal cancers with different K-ras status
- (2016) Yee-Shin Lee et al. STEROIDS
- Crosstalk between integrin αvβ3 and ERα contributes to thyroid hormone-induced proliferation of ovarian cancer cells
- (2016) Meng-Ti Hsieh et al. Oncotarget
- Actions of Thyroid Hormone Analogues on Chemokines
- (2016) Paul J. Davis et al. Journal of Immunology Research
- l-Thyroxine promotes a proliferative airway smooth muscle phenotype in the presence of TGF-β1
- (2015) Bart G. J. Dekkers et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling
- (2015) Mingde Zang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect
- (2015) Yawei Wang et al. DRUG DELIVERY
- Nongenomic actions of thyroid hormone
- (2015) Paul J. Davis et al. Nature Reviews Endocrinology
- In Vitro and In Vivo Efficacy of Self-Assembling RGD Peptide Amphiphiles for Targeted Delivery of Paclitaxel
- (2015) Poonam Saraf et al. PHARMACEUTICAL RESEARCH
- Thyroid hormone and anti-apoptosis in tumor cells
- (2015) Hung-Yun Lin et al. Oncotarget
- Low thyroid hormone levels improve survival in murine model for ocular melanoma
- (2015) Ido Didi Fabian et al. Oncotarget
- Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo
- (2015) Sheng-Huei Yang et al. Oncotarget
- Thyroid Hormone and P-Glycoprotein in Tumor Cells
- (2015) Paul J. Davis et al. Biomed Research International
- Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac
- (2015) Paul J. Davis et al. Frontiers in Endocrinology
- Thyroid hormone regulates adhesion, migration and matrix metalloproteinase 9 activity via αvβ3 integrin in myeloma cells
- (2015) Keren Cohen et al. Oncotarget
- Nanocarrier for Poorly Water-Soluble Anticancer Drugs—Barriers of Translation and Solutions
- (2014) Mayuri Narvekar et al. AAPS PHARMSCITECH
- Thyroid hormone inhibition in L6 myoblasts of IGF-I-mediated glucose uptake and proliferation: new roles for integrin αvβ3
- (2014) Sandra Incerpi et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Increased EphB2 expression predicts cholangiocarcinoma metastasis
- (2014) Walaiporn Khansaard et al. TUMOR BIOLOGY
- Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesis
- (2014) Paul Davis et al. OncoTargets and Therapy
- Nanodelivery of Bioactive Components for Food Applications: Types of Delivery Systems, Properties, and Their Effect on ADME Profiles and Toxicity of Nanoparticles
- (2014) T. Borel et al. Annual Review of Food Science and Technology
- Bile carcinoembryonic cell adhesion molecule 6 (CEAM6) as a biomarker of malignant biliary stenoses
- (2013) Annarita Farina et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Nuclear monomeric integrin αv in cancer cells is a coactivator regulated by thyroid hormone
- (2013) Hung-Yun Lin et al. FASEB JOURNAL
- Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer
- (2013) Dhruba J Bharali et al. Nanomedicine
- Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets
- (2013) Elin Hadler-Olsen et al. TUMOR BIOLOGY
- Atorvastatin overcomes gefitinib resistance in KRAS mutant human non-small cell lung carcinoma cells
- (2013) J Chen et al. Cell Death & Disease
- Cell–cell adhesion genes CTNNA2 and CTNNA3 are tumour suppressors frequently mutated in laryngeal carcinomas
- (2013) Miriam Fanjul-Fernández et al. Nature Communications
- Response of Human Pancreatic Cancer Cell Xenografts to Tetraiodothyroacetic Acid Nanoparticles
- (2013) Murat Yalcin et al. Hormones & Cancer
- αVβ3 Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug
- (2012) Nora Graf et al. ACS Nano
- Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells
- (2012) Jung-Jin Park et al. BIOCHEMICAL PHARMACOLOGY
- Single domain antibody against carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) inhibits proliferation, migration, invasion and angiogenesis of pancreatic cancer cells
- (2012) Tsai-Mu Cheng et al. EUROPEAN JOURNAL OF CANCER
- Tetraiodothyroacetic acid-tagged liposomes for enhanced delivery of anticancer drug to tumor tissue via integrin receptor
- (2012) Sangbin Lee et al. JOURNAL OF CONTROLLED RELEASE
- Present and Future of EGFR Inhibitors for Head and Neck Squamous Cell Cancer
- (2012) Yuh Baba et al. Journal of Oncology
- Membrane Receptor for Thyroid Hormone: Physiologic and Pharmacologic Implications
- (2011) Paul J. Davis et al. Annual Review of Pharmacology and Toxicology
- Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment
- (2011) Maria V. Barbolina et al. BIOCHEMICAL JOURNAL
- Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac)
- (2011) Anna B. Glinskii et al. CELL CYCLE
- Radiosensitization and production of DNA double-strand breaks in U87MG brain tumor cells induced by tetraiodothyroacetic acid (tetrac)
- (2011) Aleck H. Hercbergs et al. CELL CYCLE
- Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal Cancers
- (2011) Bryan D. White et al. GASTROENTEROLOGY
- The wnt/β-catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer
- (2011) Taj D. King et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts
- (2011) Shaker A. Mousa et al. LUNG CANCER
- Crosstalk between Integrin αvβ3 and Estrogen Receptor-α Is Involved in Thyroid Hormone-Induced Proliferation in Human Lung Carcinoma Cells
- (2011) Ran Meng et al. PLoS One
- Overlapping nongenomic and genomic actions of thyroid hormone and steroids
- (2011) Paul J. Davis et al. STEROIDS
- Models for oral uptake of nanoparticles in consumer products
- (2011) Eleonore Fröhlich et al. TOXICOLOGY
- Pharmacodynamic Modeling of Anti-Cancer Activity of Tetraiodothyroacetic Acid in a Perfused Cell Culture System
- (2011) Hung-Yun Lin et al. PLoS Computational Biology
- Tetraiodothyroacetic Acid (Tetrac) and Nanoparticulate Tetrac Arrest Growth of Medullary Carcinoma of the Thyroid
- (2010) M. Yalcin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pharmaceutical applications of cyclodextrins: basic science and product development
- (2010) Thorsteinn Loftsson et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- l-Thyroxine vs. 3,5,3′-triiodo-l-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase
- (2009) Hung-Yun Lin et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Combination chemotherapy of doxorubicin and paclitaxel for hepatocellular carcinoma in vitro and in vivo
- (2009) Cheng Jin et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice
- (2008) Paul T. Martin et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent
- (2008) Abdelhadi Rebbaa et al. ANGIOGENESIS
- Thyroid Hormone Promotes Cell Invasion through Activation of Furin Expression in Human Hepatoma Cell Lines
- (2008) Ruey-Nan Chen et al. ENDOCRINOLOGY
- Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats
- (2008) Michelle Longmire et al. Nanomedicine
- Novel cytotoxic drugs: Old challenges, new solutions
- (2007) Gustavo F.V. Ismael et al. CANCER TREATMENT REVIEWS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started